longitudin
characterist
lymphocyt
respons
cytokin
profil
peripher
blood
infect
patient
ebiomedicin
doi
http
doiabstract
background
dynam
chang
lymphocyt
subset
cytokin
profil
patient
novel
coronaviru
diseas
correl
diseas
sever
remain
unclear
method
peripher
blood
sampl
longitudin
collect
confirm
patient
examin
lymphocyt
subset
flow
cytometri
cytokin
profil
specif
immunoassay
find
patient
enrol
sever
case
show
signific
sustain
decreas
lymphocyt
count
increas
neutrophil
count
mild
case
analysi
demonstr
signific
decreas
count
cell
especi
cell
well
increas
level
peripher
blood
sever
case
compar
mild
case
cell
count
cytokin
level
sever
patient
surviv
diseas
gradual
recov
later
time
point
level
compar
mild
case
moreov
neutrophiltolymphocyt
ratio
nlr
cell
ratio
auc
identifi
power
prognost
factor
affect
prognosi
sever
interpret
degre
lymphopenia
proinflammatori
cytokin
storm
higher
sever
patient
mild
case
associ
diseas
sever
nlr
may
serv
use
prognost
factor
earli
identif
sever
case
evid
studi
lymphopenia
inflammatori
cytokin
storm
shown
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
infect
coronaviru
diseas
first
time
kinet
chang
lymphopenia
lymphocyt
subset
cytokin
profil
longitudin
character
signific
decreas
count
cell
number
increas
inflammatori
cytokin
level
eg
dynam
correl
sever
patient
cell
count
cytokin
level
sever
patient
surviv
diseas
gradual
recov
later
time
point
level
compar
mild
case
neutrophiltolymphocyt
ratio
nlr
cell
ratio
auc
identifi
power
prognost
factor
affect
prognosi
sever
develop
sever
result
imbalanc
inflamm
antivir
immun
respons
nlr
serv
use
prognost
factor
earli
identif
sever
case
help
physician
provid
time
intervent
first
report
wuhan
china
decemb
ongo
outbreak
viral
pneumonia
human
rais
acut
grave
global
concern
rapidli
spread
countri
area
territori
caus
pathogen
rapidli
identifi
novel
sinc
formal
name
sever
acut
patient
show
symptom
fever
dri
cough
fatigu
abnorm
chest
ct
find
good
prognosi
contrast
patient
develop
sever
pneumonia
acut
respiratori
distress
syndrom
ard
multipl
organ
failur
death
rate
rang
accord
differ
studi
report
lymphopenia
lymphocyt
count
inflammatori
cytokin
storm
typic
laboratori
abnorm
observ
highli
pathogen
coronaviru
infect
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
infect
believ
associ
diseas
sever
recent
studi
also
report
decreas
count
lymphocyt
eg
cell
cell
peripher
blood
increas
serum
inflammatori
cytokin
level
eg
patient
howev
remain
larg
unclear
kinet
lymphocyt
subset
inflammatori
cytokin
chang
peripher
blood
studi
longitudin
character
chang
lymphocyt
subset
cytokin
profil
peripher
blood
patient
distinct
diseas
sever
written
inform
consent
regularli
obtain
patient
upon
admiss
wuhan
union
hospit
china
studi
approv
ethic
committe
wuhan
union
hospit
tongji
medic
colleg
huazhong
univers
scienc
technolog
china
confirm
patient
wuhan
union
hospit
januari
januari
enrol
retrospect
singlecent
studi
medic
record
inform
includ
epidemiolog
demograph
clinic
manifest
laboratori
data
outcom
data
obtain
data
check
team
train
physician
laboratori
confirm
perform
local
cdc
accord
chines
cdc
protocol
throatswab
specimen
collect
patient
sampl
maintain
viraltransport
medium
laboratori
test
infect
respiratori
virus
includ
influenza
viru
influenza
b
viru
coxsacki
viru
respiratori
syncyti
viru
parainfluenza
viru
enteroviru
exclud
realtim
rtpcr
specimen
includ
sputum
bronchoalveolar
lavag
fluid
blood
urin
fece
cultur
identifi
pathogen
bacteria
fungi
may
associ
infect
specif
igg
igm
chlamydia
pneumonia
mycoplasma
pneumonia
detect
chemiluminesc
immunoassay
lymphocyt
test
kit
beckman
coulter
inc
fl
usa
use
lymphocyt
subset
analysi
plasma
cytokin
tnf
detect
use
human
cytokin
kit
ii
bd
ltd
franklin
lake
nj
usa
test
perform
accord
product
manual
classif
variabl
express
frequenc
percentag
signific
detect
chi
squar
fisher
exact
test
quantiz
variabl
paramet
express
mean
standard
deviat
signific
test
ttest
nonparametr
variabl
express
median
quartil
interv
signific
test
mann
whitney
u
kruskal
walli
test
data
nonnorm
distribut
repeat
measur
compar
use
gener
linear
diagnosi
patient
perform
accord
guidelin
tabl
patient
exposur
histori
shop
huanan
seafood
market
wuhan
medium
age
patient
year
old
age
sever
patient
group
year
older
mild
group
year
durat
hospit
tabl
sever
patient
mild
patient
fever
signific
differ
degre
temperatur
observ
two
group
tabl
sever
patient
show
significantli
higher
frequenc
occurr
sputum
product
myalgia
nausea
three
patient
sever
group
develop
acut
respiratori
distress
syndrom
ard
patient
receiv
antivir
treatment
includ
interferon
ribavirin
abidol
andor
oseltamivir
well
antibiot
treatment
includ
moxifloxacin
cephalosporin
penicillin
andor
antibiot
seventeen
patient
receiv
antifung
treatment
case
took
prophylact
treatment
receiv
methylprednisolon
therapi
mild
case
sever
case
tabl
level
fibrinogen
ddimer
total
bilirubin
aspart
transaminas
alanin
transaminas
lactat
dehydrogenas
creatin
kinas
creactiv
protein
crp
ferritin
serum
amyloid
protein
saa
peripher
blood
sever
patient
significantli
higher
admiss
compar
mild
patient
tabl
signific
differ
serum
level
immunoglobulin
iga
igg
igm
complement
observ
two
group
tabl
also
analyz
impact
methylprednisolon
treatment
lymphocyt
neutrophil
count
well
cytokin
level
result
show
patient
methylprednisolon
treatment
higher
lymphocyt
count
lower
neutrophil
count
nlr
serum
level
patient
without
methylprednisolon
treatment
howev
differ
statist
signific
tabl
lymphopenia
observ
mild
patient
sever
patient
onset
diseas
shown
tabl
absolut
count
lymphocyt
peripher
blood
sever
patient
significantli
lower
absolut
count
total
white
blood
cell
wbc
neutrophil
significantli
higher
mild
patient
time
hospit
admiss
signific
differ
monocyt
count
observ
two
group
tabl
next
analyz
kinet
chang
wbc
neutrophil
monocyt
well
differ
lymphocyt
subset
peripher
blood
patient
diseas
onset
least
day
later
three
mortal
sever
group
exclud
analysi
due
lack
kinet
data
signific
increas
total
wbc
count
sever
group
figur
contrast
signific
decreas
lymphocyt
count
sever
group
observ
time
point
diseas
onset
becam
even
greater
day
later
compar
mild
patient
figur
signific
differ
monocyt
count
observ
two
group
whole
observ
period
figur
order
determin
kinet
chang
differ
lymphocyt
subset
peripher
blood
patient
perform
flow
cytometri
stain
cell
cell
subset
b
cell
nk
cell
similar
find
lymphocyt
sustain
decreas
cell
count
observ
sever
group
compar
mild
patient
clinic
observ
figur
c
figur
lowest
cell
count
observ
day
diseas
onset
figur
differ
cell
count
two
group
signific
time
point
diseas
onset
day
later
figur
howev
differ
cell
count
two
group
reach
statist
signific
time
point
figur
cell
count
start
gradual
increas
sever
group
start
day
diseas
onset
reach
compar
level
mild
patient
day
diseas
onset
figur
c
signific
differ
b
cell
nk
cell
count
observ
two
group
whole
cours
diseas
figur
previou
studi
demonstr
chang
inflammatori
cytokin
level
serum
patient
therefor
character
kinet
chang
inflammatori
cytokin
level
includ
serum
patient
cohort
fluctuat
serum
level
cytokin
mild
patient
group
minor
contrast
sever
patient
group
show
signific
fluctuat
serum
level
cytokin
figur
examin
cytokin
except
reach
peak
level
serum
day
diseas
onset
figur
level
show
sustain
increas
sever
group
compar
mild
group
figur
reduct
serum
level
sever
group
start
day
diseas
onset
level
lowest
day
diseas
onset
figur
signific
increas
serum
level
sever
group
observ
day
diseas
onset
figur
signific
differ
level
observ
two
group
whole
cours
diseas
figur
examin
cytokin
reach
similar
level
sever
mild
patient
group
day
diseas
onset
figur
observ
higher
crp
level
sever
group
mild
group
time
point
howev
differ
signific
figur
moreov
also
perform
analys
exclud
patient
fungal
coinfect
sever
patient
group
observ
level
show
sustain
increas
sever
group
compar
mild
group
figur
signific
increas
serum
level
sever
group
observ
day
diseas
onset
figur
signific
differ
level
observ
two
group
whole
cours
diseas
figur
next
examin
possibl
use
abovement
paramet
prognost
factor
identifi
sever
case
patient
pca
firstli
perform
r
packag
factoextra
identifi
correl
variabl
distinguish
sever
patient
mild
patient
figur
four
contribut
variabl
cell
ratio
neutrophiltolymphocyt
ratio
nlr
neutrophil
count
nec
white
blood
cell
count
wbcc
select
potenti
prognost
factor
detail
statist
analysi
assess
diagnost
valu
four
select
paramet
receiv
oper
characterist
roc
curv
area
roc
curv
auc
calcul
r
packag
proc
figur
result
analysi
identifi
higher
auc
nlr
ne
wbc
figur
simultan
cutoff
valu
calcul
roc
curv
valu
specif
sensit
nlr
predict
perform
nlr
still
signific
fungal
coinfect
case
exclud
group
figur
studi
analyz
clinic
featur
immunolog
characterist
peripher
blood
patient
although
major
patient
exposur
histori
huanan
seafood
market
wuhan
clinic
characterist
patient
similar
report
previou
studi
sever
patient
age
well
proport
underli
diseas
higher
coinfect
also
occur
recent
report
show
lymphocyt
count
normal
patient
mild
diseas
contrast
patient
sever
diseas
lymphopenia
lymphocyt
count
patient
mortal
outcom
remain
low
level
studi
also
confirm
higher
rate
develop
lymphopenia
sever
patient
mild
patient
vs
recent
studi
report
infect
may
primarili
affect
lymphocyt
particularli
cell
might
highli
involv
patholog
process
also
found
develop
lymphopenia
sever
patient
mainli
relat
significantli
decreas
absolut
count
cell
especi
cell
absolut
count
b
cell
nk
cell
decreas
cell
sever
patient
group
reach
peak
within
first
week
diseas
cours
cell
number
gradual
increas
second
week
recov
compar
level
mild
patient
group
third
week
sever
patient
includ
studi
surviv
diseas
thu
specul
cours
associ
favor
outcom
sever
patient
recent
studi
cohort
report
nlr
use
prognost
factor
affect
prognosi
sever
immunolog
marker
eg
cell
cell
nlr
tend
independ
predictor
sever
treatment
efficaci
sever
patholog
injuri
sar
mer
correl
extens
infiltr
neutrophil
lung
increas
neutrophil
number
peripher
blood
thu
magnitud
increas
neutrophil
count
may
suggest
intens
inflammatori
respons
patient
besid
magnitud
decreas
lymphocyt
count
also
indic
extent
impair
immun
system
viral
infect
therefor
nlr
may
serv
use
factor
reflect
intens
imbal
inflamm
immun
respons
patient
studi
also
screen
potenti
prognost
factor
affect
incid
sever
ill
patient
cohort
base
find
analyz
lymphocyt
subset
includ
ratio
neutrophil
differ
lymphocyt
subset
paramet
kinet
analysi
reveal
cell
major
lymphocyt
subset
decreas
cell
number
line
find
result
demonstr
compar
perform
nlr
roc
curv
analysi
nlr
may
serv
power
factor
predict
sever
ill
incid
covid
patient
summari
studi
immunolog
characterist
peripher
blood
patient
show
number
neutrophil
cell
especi
cell
well
level
inflammatori
cytokin
peripher
blood
dynam
correl
sever
diseas
best
knowledg
first
work
describ
kinet
chang
lymphocyt
subset
cytokin
profil
patient
importantli
identifi
nlr
power
prognost
factor
earli
identif
sever
case
work
may
help
achiev
better
understand
immun
function
disord
well
immunopathogenesi
infect
help
physician
provid
time
intervent
thank
doctor
nurs
diseas
control
worker
research
fought
brave
ceaseless
viru
frontlin
epidem
lost
live
thank
given
great
selfless
support
fight
viru
thank
ms
delia
cosgrov
ms
ursula
schrammel
languag
correct
manuscript
work
support
nation
natur
scienc
foundat
china
sourc
studi
play
role
studi
design
collect
analysi
interpret
data
write
manuscript
decis
submit
paper
public
author
disclos
conflict
interest
gl
gl
